Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 19, 2018
- Accepted after revision September 8, 2018
- Published online November 22, 2018.
Article Versions
- You are currently viewing a Latest version of this article (November 22, 2018 - 08:32).
- View the most recent version of this article
Copyright & Usage
© 2018 by American Journal of Neuroradiology Indicates open access to non-subscribers at www.ajnr.org
Author Information
- E. Ghionea,
- N. Bergslanda,
- M.G. Dwyera,c,
- J. Hagemeiera,
- D. Jakimovskia,
- I. Paunkoskia,
- D.P. Ramasamya,
- D. Silvad,
- E. Carla,
- D. Hojnackib,
- C. Kolbb,
- B. Weinstock-Guttmanb and
- R. Zivadinova,c
- aFrom the Department of Neurology (E.G., N.B., M.G.D., J.H., D.J., I.P., D.P.R., E.C., R.Z.), Buffalo Neuroimaging Analysis Center
- bJacobs Comprehensive MS Treatment and Research Center (D.H., C.K., B.W.-G.), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York
- cCenter for Biomedical Imaging at Clinical Translational Research Center (M.G.D., R.Z.), State University of New York, Buffalo, New York
- dNovartis Pharmaceuticals AG (D.S.), Basel, Switzerland.
- Please address correspondence to Robert Zivadinov, MD, PhD, Buffalo Neuroimaging Analysis Center, Center Biomedical Imaging at Clinical Translational Research Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, 100 High St, Buffalo, NY 14203; e-mail: rzivadinov{at}bnac.net
Funding
Research reported in this publication was funded by the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under award Number UL1TR001412. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Study was supported in part by Novartis Pharmaceuticals AG, Switzerland.